Skip to main content
SpringerLink
Log in

Brain tumor survival: Results from the National Cancer Data Base

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Hospital-based data reported to the National Cancer Data Base (NCDB) were available for over 60,000 patients with a primary brain tumor diagnosed from 1985–1988 and 1990–1992. The most common histologies were glioblastomas, astrocytomas and meningiomas. Five-year survival rates for these tumors were 2%, 30% and 70% respectively. Histology, age at diagnosis, behavior, and location were important variables in estimating survival. Comparisons with population-based registry data suggest that the malignant tumors are well represented in NCDB, but the benign histologies are under-reported. Survival estimates for the malignant tumors are comparable to previously reported studies. The NCDB provides recent information on brain tumor distribution and survival patterns not available in other large databases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kosary CL, Ries LAG, Miller BA, Hankey BF, Harras A, Edwards BK (eds): SEER cancer statistics review, 1973–1992: tables and graphs. NIH Pub. No. 96-2789. Natl Canc Inst, Bethesda, MD, 1995

    Google Scholar 

  2. Mahaley MS, Mettlin C, Natarajan N, Laws ER Jr., Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826–836, 1989

    Google Scholar 

  3. CBTRUS (1997): Annual Report. Published by the Central Brain Tumor Registry of the United States

  4. Steele GD, Osteen RT, Winchester DP, Menck HR, Murphy GP (eds): National Cancer Data Base Annual Review of Patient Care 1994. Atlanta: Amer Canc Soc, 1994

    Google Scholar 

  5. Steele GD Jr., Jessup JM, Winchester DP, Menck HR, Murphy GP: National Cancer Data Base Annual Review of Patient Care: 1995. Atlanta, Amer Canc Soc, 1995

    Google Scholar 

  6. Menck HR, Cunningham MP, Jessup JM, Eyre HJ, Winchester DP, Scott-Conner CEH, Murphy GP: The growth and maturation of the National Cancer Data Base. Cancer 80: 2296–2304, 1997

    Google Scholar 

  7. Jessup JM, Menck HR, Winchester DP, Hundahl SA, Murphy GP: The National Cancer Data Base report on patterns of hospital reporting. Cancer 78: 1829–1837, 1996

    Google Scholar 

  8. Menck HR, Blakenship C, Fremgen AM: The National Cancer Data Base and physician network. Topics Health Inform Mgt. 17: 45–59, 1997

    Google Scholar 

  9. Smart CR, Karnell LH, Eberle C, Zippin C, Lum D, Clive R, Ocwieja KS: Quality control considerations of the National Cancer Data Base. In: Steele GD, Osteen RT, Winchester DP, Menck HR, Murphy GP (eds) National Cancer Data Base Annual Review of Patient Care 1994. Atlanta: American Cancer Society, 1994, pp 117–126

    Google Scholar 

  10. Smart CR, Menck HR, Eberle C, Simon S: An assessment of National Cancer Data Base quality control. In: Steele GD, Winchester DP, Menck HR, Murphy GP (eds) National Cancer Data Base Annual Review of Patient Care 1993. Atlanta: American Cancer Society, 1993, pp 103–111

    Google Scholar 

  11. Percy C, van Holten V, Muir CM (eds): International Classification of Diseases for Oncology. (2nd, ed.) World Health Organization, Geneva, Switzerland, 1990

    Google Scholar 

  12. SAS/STAT User's Guide, Version 6, ed. 4, Cary, NC: SAS Institute, Inc. Volumes 1 and 2, 1988

  13. Armitage P, Berry G: Statistical methods in medical research. 2nd. ed., Blackwell Scientific Publications, Oxford. 1987

    Google Scholar 

  14. Cox DR: Regression models and life tables. Journal of the Royal Statistical Society, series B, 74: 187–220, 1972

    Google Scholar 

  15. Clive HE, Ocwicja KM, Kamell L, Hoyler SS, Seiffert JE, Young JL, Henson DE, Winchester DP, Osteen RT, Menck HR, Fremgen A: A national quality improvement effort: cancer registry data. J Surg Oncol 58: 155–161, 1995

    Google Scholar 

  16. Henson DE, Ries LAG: On the estimation of survival. Sem Surg Oncol 10: 2–6, 1994

    Google Scholar 

  17. Davis FG, Freels S, Grutsch J, Barlas S, Brem S: Survival of patients with primary malignant brain tumors by age and histologic groupings from Surveillance, Epidemiology, and End Results data (SEER 1973–1991). J Neurosurg 88: 1–10, 1998

    Google Scholar 

  18. Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59: 1617–1625, 1987

    Google Scholar 

  19. Winger MJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71: 487–493, 1989

    Google Scholar 

  20. Melendon RE, Robinson JS, Chambers DB, Grufferman S, Burger PC: The glioblastoma multiforme in Georgia, 1977–1981. Cancer 65: 894–897, 1985

    Google Scholar 

  21. Polednak AP, Flannery JT: Brain, other central nervous system, and eye cancer. Cancer 75: 330–337, 1995

    Google Scholar 

  22. Novakovic B: U.S. childhood cancer survival, 1973–1987. Medical and pediatric oncology 23: 480–486, 1994

    Google Scholar 

  23. Shugg D, Allen BJ, Blizzard L, Dwyer T, Roder D: Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer 59: 765–770, 1994

    Google Scholar 

  24. Preston-Martin S, Staples M, Farrugia H, Giles G: Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982–1990: patterns of incidence and survival. Neuroepidemiology 12: 270–279, 1993

    Google Scholar 

  25. Levi F, Va Vecchia C, Te VC: Descriptive epidemiology of malignant brain tumors in the Swiss canton de Vaud. Neuroepidemiology 9: 135–142, 1990

    Google Scholar 

  26. Kallio M, Sankila R, Jääskeläinen J, Karalainen S, Hakulinen T: A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953–1984. Cancer 68: 1394–1400, 1991

    Google Scholar 

  27. Sant M, Crosignani P, Bordo BM, Nicola G, Bianchi M, Berrino F: Incidence and survival of brain tumors: a population-based study. Tumori 74: 243–252, 1988

    Google Scholar 

  28. Grant R, Liang BC, Page MA, Crane DL, Greenberg HS, Junck L: Age influences chemotherapy response in astrocytomas. Neurology 45: 929–933, 1995

    Google Scholar 

  29. Takeuchi K, Sano K, Nomura K: An epidemiological study of brain tumors in the elderly. Neurological Research 13: 21–25, 1991

    Google Scholar 

  30. Phuphanich S, Ferrall S, Greenberg H: Long term survival in malignant glioma. J Florida M.A. March 1993 Vol. 80 # 3

  31. Ayoubi S, Walter PH, Naik S, Sankaran M, Robinson D: Audit in the management of gliomas. Brit J Neurosurg 1993 (abstract)

  32. Hershatter BW, Happerin EC, Cox EB: Medulloblastoma: The Duke University medical center experience. Int J Radiat Oncol Biol Phys 12: 1771–1777, 1986

    Google Scholar 

  33. Farwell JR, Dohrmann GJ, Flannery JT: Medulloblastoma in childhood: an epidemiologic study. J Neurosurg 61: 657–664, 1984

    Google Scholar 

  34. Mealey J, Hall PV: Medulloblastoma in children. Survival and treatment. J Neurosurg 46: 56–64, 1977

    Google Scholar 

  35. Saran FH, Hernaiz-Driever P, Thilmann C, Mose S, Adamietz IA, Bottcher HD: Survival of children with medullo-blastoma treated with craniospinal irradiation — age at presentation as prognostic factor. Jrnl of Neuro-Oncology, 30: 139, 1996. Abstract

    Google Scholar 

  36. Helseth A: Incidence and survival of intracranial meningioma patients in Norway 1963–1992. Neuroepidemiology 16: 53–59, 1997

    Google Scholar 

  37. McCarthy BJ, Davis F, Freels S, Surawiez TS, Damek D, Grutsch J, Menck HR, Laws ER: Factors associated with survival in patients with meningioma. Neurosurg Focus 2(4): 1–8, 1997

    Google Scholar 

  38. Winger MJ, Macdonald DR, Schold C, Cairneross JG: Selection bias in clinical trials of anaplastic glioma. Ann of Neurol: 26: 531–534, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CBTRUS project, Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA

    Tanya S. Surawicz, Faith Davis & Sally Freels

  2. Department of Neurological Surgery, University of Virginia Health Sciences Center, Charlottesville, VA, USA

    Edward R. Laws Jr.

  3. Clinical Information, National Cancer Data Base, Commission on Cancer of the American College of Surgeons, Chicago, IL, USA

    Herman R. Menck

Authors
  1. Tanya S. Surawicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Faith Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sally Freels
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Edward R. Laws Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Herman R. Menck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Surawicz, T.S., Davis, F., Freels, S. et al. Brain tumor survival: Results from the National Cancer Data Base. J Neurooncol 40, 151–160 (1998). https://doi.org/10.1023/A:1006091608586

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006091608586

Search

Navigation